Contents
On this page
- Essential elements of a prospective-study question
- Evaluation of the question with the FINER and PICOT frameworks
- Worked example from a published cohort study
- Carrying the question into registration and reporting
- Determining the number of sub-questions in a prospective study
- Comparison with other evidence-based practice frameworks
Academy · Research Data, Analytics & AI · Prospective Study Questions
Formulating a Good Research Question for a Prospective Study: The PICOT and FINER Frameworks
A workable prospective-study question specifies the exposure, the population, the outcome and the follow-up period before data collection begins, because each of these four elements determines a design decision that cannot be corrected retrospectively.
A prospective study follows a defined group forward in time to determine whether an exposure is associated with a later outcome, which means that the research question must be settled before enrollment starts, not refined once data exist. Unlike a retrospective or cross-sectional question, a prospective question fixes a follow-up period, an exposure definition, and an outcome definition that will govern data collection for months or years. Errors in these elements are far more costly in a prospective design than in designs where the dataset already exists, because there is no equivalent dataset to query differently once the cohort has been assembled and followed.
Prospective-study questions at a glance
- Must fix before enrolment
- Population, exposure, outcome and follow-up period
- Structure test
- PICOT: Population, Intervention or exposure, Comparison, Outcome, Time11
- Worth test
- FINER: Feasible, Interesting, Novel, Ethical, Relevant13
- Reported under
- STROBE, with the question’s wording carried forward unchanged6
- First decision
- Is the study confirmatory or exploratory? The two need different frameworks and analysis plans
- Reading time
- About 12 minutes, with 2 figures and 5 tables
Learning objectives
- The four structural elements a prospective-study question needs before enrollment begins
- Why the FINER and PICOT frameworks are designed to test a question before data collection
- How the question of a published cohort study illustrates each required element
- What may change, and what must remain fixed, once the study question is carried into registration and reporting
Common misconceptions
- “A good research question just needs to be interesting; the methods can be worked out once data collection starts.” Published guidance on question formulation, including the FINER criteria and the PICOT format, treats feasibility, exposure definition, and outcome definition as matters to be settled before a study begins, specifically because a prospective design cannot retrofit a missing exposure measurement or outcome definition once follow-up is already underway.
Essential elements of a prospective-study question
A prospective-study question should specify, at minimum, the population being followed, the exposure or intervention being examined, the outcome being measured, and the length of follow-up, because each of these determines a concrete design decision rather than a stylistic preference1. The population determines eligibility criteria and recruitment strategy; the exposure determines what has to be measured at baseline and how often; the outcome determines what has to be tracked and how it will be adjudicated; and the follow-up period determines the study's total duration and its vulnerability to attrition2. The PICOT format, an extension of the clinical-question structure originally built for treatment comparisons, makes the Time element explicit precisely because prospective designs cannot answer a question properly without a stated follow-up window11. A question that omits any one of these four elements is not merely less refined but structurally incomplete, because the missing element corresponds to a decision that the study team must make, deliberately or otherwise, once enrollment begins.
Combined into one questionIn adults free of ischaemic heart disease at baseline, is regular leisure-time physical activity, compared with little or no leisure-time activity, associated with a lower incidence of ischaemic heart disease over ten years of follow-up?
The design decision each element fixes
| Element | Decides | Why it cannot wait |
|---|---|---|
| Population | Eligibility criteria and the recruitment strategy | Once the cohort is assembled, its make-up is fixed |
| Exposure | What is measured at baseline, and how often it is re-measured | A baseline measurement that was never taken cannot be recovered |
| Comparison | The reference group and the contrast the analysis estimates | Categories defined after seeing the data invite selective reporting |
| Outcome | What is tracked and how events are adjudicated | Events missed during follow-up cannot be ascertained later |
| Time | Total study duration and exposure to attrition | Follow-up that is too short cannot be extended for participants already lost |
Compiled for this guide from the section above.
Evaluation of the question with the FINER and PICOT frameworks
Hulley and colleagues' FINER criteria, widely used in clinical research training, ask whether a question is Feasible, Interesting, Novel, Ethical, and Relevant, and the feasibility check in particular requires an early, candid assessment of whether the exposure and outcome can be measured in the population and timeframe available4. Riva and colleagues' introduction to the PICOT format for clinicians makes a parallel point about the wording of the question: a question that cannot be broken into Population, Intervention or exposure, Comparison, Outcome, and Time is usually too vague to guide a protocol, and the exercise of forcing it into that structure routinely reveals gaps the author had not recognized1. Applied together, FINER checks whether the question justifies the resources a prospective design demands, and PICOT checks whether the question is specific enough for that design to answer it. Applying both checks before writing a protocol, rather than after a first draft exists, allows a feasibility problem to be identified on paper rather than three years into a cohort's follow-up.
The FINER criteria applied to a prospective study
| Criterion | Ask before enrolment | Prospective-study warning sign |
|---|---|---|
| Feasible | Can the exposure and outcome be measured in the population and time available? | The expected number of outcome events within follow-up is too small to answer the question |
| Interesting | Would the answer matter to clinicians, patients or the research team? | Nobody can say what they would do differently with the result |
| Novel | Does it confirm, refute or extend earlier findings? | Existing cohorts already answer it with longer follow-up |
| Ethical | Can it be studied without undue burden or risk to participants? | Repeated invasive measurements are needed only to fill the exposure element |
| Relevant | Will it inform practice, policy or the next study? | The decision the findings would inform cannot be named |
Criteria as named in the clinical research literature413; the questions and warning signs are illustrative, written for this guide.
Weak prospective question
“Is exercise good for the heart?”
No population, no definition of exposure or comparison, no outcome definition and no follow-up period: each is a design decision left to be made after enrolment.
Strong prospective question
“In adults free of ischaemic heart disease at baseline, is regular leisure-time physical activity, compared with little or none, associated with a lower incidence of ischaemic heart disease over ten years?”
All five PICOT elements are stated, so FINER can be applied to something concrete. Illustrative example.
Worked example from a published cohort study
The Global Burden of Disease dose-response meta-analysis by Kyu and colleagues, which pooled 174 prospective cohort studies on physical activity and chronic disease, illustrates how all four elements operate together at the level of an individual cohort's research question: a defined population (adults free of the outcome at baseline), a defined exposure (leisure-time physical activity, measured and categorized consistently), defined outcomes (incident breast cancer, colon cancer, diabetes, ischemic heart disease, and ischemic stroke, each with its own case definition), and a stated follow-up period long enough for those outcomes to occur5. The methodology section of the review shows how heterogeneity in these four elements across the pooled cohorts complicated the analysis, which underscores the value of specifying them precisely at the design stage of an individual study rather than retrospectively; this value is most evident when the study's data are later compared with others in a pooled synthesis of this kind.
Carrying the question into registration and reporting
Once a prospective study's question is finalized, the STROBE statement for reporting observational studies recommends stating the specific objectives and any pre-specified hypotheses in the introduction of the eventual report, which is easiest to do accurately when the original FINER- and PICOT-checked question is simply carried forward rather than reconstructed after analysis6. The Sicily Statement on evidence-based practice, which helped standardize how clinical questions are taught and formulated across disciplines, makes the same point in general terms: a well-built question is the first and most consequential step in the entire evidence-based practice cycle, and weaknesses introduced there propagate through every later step, including how the finished study is ultimately interpreted by its own readers7. Many funders and registries now also require the exposure, outcome, and follow-up period to be stated at registration, before any data are collected, which gives the FINER-and-PICOT exercise a second, independent checkpoint beyond the study team's own judgment.
Figure 2. Thabane and colleagues’ review of published anaesthesia research (95% confidence interval for the 96%: 91 to 100). The authors note that whether PICOT reporting is linked to better research reporting has yet to be determined.11
What peer-reviewed papers say about structuring the question
| Paper | Type | What it reports |
|---|---|---|
| Thabane et al., 2009, Canadian Journal of Anesthesia11 | Guidance with a systematic review of 313 articles | Defines PICOT with Time as the time frame over which outcomes are assessed; 96% of reviewed articles did not use it to state the question |
| Bahadoran et al., 2025, Addiction & Health12 | Practical guide | Recommends PICOT, or PECOT where there is an exposure, for relational quantitative questions, and FINER to judge whether a question is worth answering |
| Willis, 2023, Respiratory Care13 | Practical guide | Advises devising the question and hypothesis before study initiation, using FINER to test the question and PICO to structure and narrow it |
| Jordan et al., 2019, AEM Education and Training14 | Pilot study of a research consultation session | Participants’ study questions scored higher on PICO (60% relative increase) and FINER (16%) after consultation; neither change was statistically significant |
Each row is described from the paper’s abstract, retrieved from PubMed in November 2026.
Determining the number of sub-questions in a prospective study
A prospective study built around one core PICOT question can often support a small number of secondary or sub-questions, for example examining whether an association differs by sex or by baseline severity, without requiring an entirely separate design3. Guidance on structuring these sub-questions generally recommends keeping them few, typically no more than four or five, and built around the same core population and exposure, rather than letting the study drift into a loosely connected set of unrelated questions8. A study that appears to require many more sub-questions than this usually indicates that its core question was defined too broadly, and the more effective remedy is almost always to narrow the primary question rather than to add secondary questions to compensate for that breadth.
Takeaway: one core question, few sub-questions
Keep secondary questions to a handful, each built on the same population and exposure as the primary question. If the list keeps growing, narrow the primary question instead of adding more.
Comparison with other evidence-based practice frameworks
PICOT is the appropriate tool for most prospective cohort questions because the design already commits to a comparison group and a follow-up window, but it should not be adopted by habit. Methley and colleagues’ direct comparison of PICO-family tools found that frameworks differ in sensitivity and specificity when applied to a real database, so the choice is not cosmetic3. An explicitly exploratory cohort, intended to map which exposures and outcomes are worth studying in a later, more tightly defined cohort, is better served by a PCC-style scoping framework than by a premature PICOT statement10. The first decision is therefore whether the study is confirmatory or exploratory.
Confirmatory and exploratory prospective studies compared
| Confirmatory | Exploratory | |
|---|---|---|
| Purpose | Test a specific, prespecified hypothesis | Map which exposures and outcomes merit a future confirmatory study |
| Question framework | PICOT, or PECOT for an exposure | A PCC-style scoping framework |
| Sample size and analysis | Planned around the prespecified hypothesis | A different plan, not the PICOT template completed with more tentative language |
| Common error | A stated hypothesis that the analysis plan does not test | Pilot aims written in rigid PICOT language that promise prespecified testing the pilot cannot deliver |
State in the protocol
- One sentence saying whether the study is confirmatory or exploratory; reviewers routinely ask when a manuscript’s hypothesis and analysis plan do not clearly correspond.
- The decision or policy the findings are intended to inform, which funders of new cohorts frequently ask about.
- Exposure, outcome and time elements defined concretely enough to support that decision once the data are available.
Key points
Key points
The population, exposure, outcome and follow-up period should be settled before enrollment, the question should be tested against the FINER and PICOT frameworks, and the same wording should be carried forward into STROBE-style reporting.
Practical application
Practical application
- The question should be written in full PICOT form before the protocol is finalized. Population, Intervention/exposure, Comparison, Outcome and Time should each be stated explicitly; a question that resists this structure is usually not yet sufficiently specific.
- The FINER feasibility check should be applied rigorously. Investigators should confirm that the exposure and outcome can be measured in the accessible population and timeframe before committing to a multi-year follow-up.
- Outcome definitions and the follow-up window should be pre-specified in writing. The method of outcome adjudication and the duration of follow-up should be determined before enrollment starts, since neither can be retrofitted once the study is underway.
- Sub-questions should be limited to a small number built around the same core exposure. The addition of many sub-questions should be treated as a signal to narrow the core question rather than as a reason to expand the scope.
- The wording of the original question should be retained in the STROBE-aligned report. The introduction and methods should use the same population, exposure, outcome and time terms that were used to design the study.
Frequently asked questions
A retrospective or cross-sectional study can sometimes query an existing dataset in a new way if the first question proves unproductive; a prospective study commits to measuring a specific exposure and outcome over a specific follow-up period before any data exist, so the question must be correctly specified before enrollment starts.
Most prospective cohort questions involve comparing an exposed and unexposed (or differently exposed) group, but the comparison can be internal to the cohort rather than a separate study arm; what matters is that the comparison is defined before follow-up begins.
Guidance generally favors a small number, often no more than four or five, built around the same core population and exposure; needing many more than that is usually a sign the core question is too broad rather than a reason to add further sub-questions.
It can, but every change should be documented and justified, since an outcome definition set after exposure data begin to accumulate risks being shaped by the results rather than by a prespecified rule, which is one of the concerns STROBE-style reporting asks authors to address directly.
It creates an independent, time-stamped record of the original question and its exposure, outcome, and follow-up definitions, which protects against unacknowledged drift of the question toward whatever the data eventually show and gives reviewers and readers a fixed point of comparison against the final published report.
References
- Riva JJ, Malik KM, Burnie SJ, Endicott AR, Busse JW. What is your research question? An introduction to the PICOT format for clinicians. Journal of the Canadian Chiropractic Association. 2012;56(3):167-171. read 10 October 2026. View on PMC
- Rothman KJ, Greenland S, Lash TL. Modern Epidemiology. 3rd ed. Lippincott Williams & Wilkins; 2008. read 10 October 2026. Find this edition
- Methley AM, Campbell S, Chew-Graham C, McNally R, Cheraghi-Sohi S. PICO, PICOS and SPIDER: a comparison study of specificity and sensitivity in three search tools for qualitative systematic reviews. BMC Health Services Research. 2014;14:579. read 10 October 2026. View on BMC Health Services Research
- Hulley SB, Cummings SR, Browner WS, Grady DG, Newman TB. Designing Clinical Research. 4th ed. Lippincott Williams & Wilkins; 2013. read 10 October 2026. Find this edition
- Kyu HH, Bachman VF, Alexander LT, et al. Physical activity and risk of breast cancer, colon cancer, diabetes, ischemic heart disease, and ischemic stroke events: systematic review and dose-response meta-analysis for the Global Burden of Disease Study 2013. BMJ. 2016;354:i3857. read 10 October 2026. View on The BMJ
- von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453-1457. read 10 October 2026. View on PMC
- Dawes M, Summerskill W, Glasziou P, et al. Sicily statement on evidence-based practice. BMC Medical Education. 2005;5:1. read 10 October 2026. View on BMC Medical Education
- Richardson WS, Wilson MC, Nishikawa J, Hayward RS. The well-built clinical question: a key to evidence-based decisions. ACP Journal Club. 1995;123(3):A12-13. read 10 October 2026. View on PubMed
- Peters MDJ, Godfrey CM, Khalil H, McInerney P, Parker D, Soares CB. Guidance for conducting systematic scoping reviews. International Journal of Evidence-Based Healthcare. 2015;13(3):141-146. read 10 October 2026. View on IJEBH
- Munn Z, Peters MDJ, Stern C, Tufanaru C, McArthur A, Aromataris E. Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Medical Research Methodology. 2018;18:143. read 10 October 2026. View on BMC Medical Research Methodology
- Thabane L, Thomas T, Ye C, Paul J. Posing the research question: not so simple. Canadian Journal of Anesthesia. 2009;56(1):71-79. read 13 November 2026. doi.org/10.1007/s12630-008-9007-4
- Bahadoran Z, Mirmiran P, Kashfi K, Ghasemi A. Biomedical research: formulating a well-built and worth-answering research question. Addiction & Health. 2025;17:1564. read 13 November 2026. doi.org/10.34172/ahj.1564
- Willis LD. Formulating the research question and framing the hypothesis. Respiratory Care. 2023;68(8):1180-1185. read 13 November 2026. doi.org/10.4187/respcare.10975
- Jordan J, Shah K, Phillips AW, Hartman N, Love J, Gottlieb M. Use of the “step-back” method for education research consultation at the national level: a pilot study. AEM Education and Training. 2019;3(4):347-352. read 13 November 2026. doi.org/10.1002/aet2.10349
Every source above is a peer-reviewed article, a publisher’s record of one, or a standard issued by the body that owns it. Each carries the date it was last read. Where a standard moves, this article is revised rather than left up with a note.
How to cite this article
Pick your referencing style and copy it. Your university or target journal may vary the punctuation — check its guide if it has one.
Pubrica Academy. (2026, October 10). Formulating a Good Research Question for a Prospective Study: The PICOT and FINER Frameworks. Pubrica. https://pubrica.com/academy/case-reporting/what-is-a-good-research-question-for-prospective-studies/
Pubrica Academy. “Formulating a Good Research Question for a Prospective Study: The PICOT and FINER Frameworks.” Pubrica, 10 Oct. 2026, pubrica.com/academy/case-reporting/what-is-a-good-research-question-for-prospective-studies/.
Pubrica Academy (2026) Formulating a Good Research Question for a Prospective Study: The PICOT and FINER Frameworks. Pubrica. Available at: https://pubrica.com/academy/case-reporting/what-is-a-good-research-question-for-prospective-studies/ (Accessed: 15 October 2026).
Pubrica Academy. “Formulating a Good Research Question for a Prospective Study: The PICOT and FINER Frameworks.” Pubrica. October 10, 2026. https://pubrica.com/academy/case-reporting/what-is-a-good-research-question-for-prospective-studies/
Pubrica Academy, ‘Formulating a Good Research Question for a Prospective Study: The PICOT and FINER Frameworks’ (Pubrica, 10 October 2026) <https://pubrica.com/academy/case-reporting/what-is-a-good-research-question-for-prospective-studies/> accessed 15 October 2026.
Pubrica Academy. Formulating a Good Research Question for a Prospective Study: The PICOT and FINER Frameworks. [Internet]. Pubrica; 2026 Oct 10 [cited 2026 Oct 15]. Available from: https://pubrica.com/academy/case-reporting/what-is-a-good-research-question-for-prospective-studies/
Pubrica Academy, “Formulating a Good Research Question for a Prospective Study: The PICOT and FINER Frameworks,” Pubrica, Oct. 10, 2026. [Online]. Available: https://pubrica.com/academy/case-reporting/what-is-a-good-research-question-for-prospective-studies/
@misc{/la_research_question_prospective_studies_2026,
author = {{Pubrica Academy}},
title = {Formulating a Good Research Question for a Prospective Study: The PICOT and FINER Frameworks},
howpublished = {Pubrica},
year = {2026},
month = {oct},
url = {https://pubrica.com/academy/case-reporting/what-is-a-good-research-question-for-prospective-studies/},
note = {Accessed: <span data-cite-acc="iso">2026-10-15</span>}
}This article is written to be learned from. Cite it if you are referring to what it says; if you are using the evidence behind it, cite the sources listed above instead.
Prospective Question Builder (PICOT + FINER)
This tool should be completed before the protocol is written.
Population: ____________________ Exposure/Intervention: ____________________ Comparison: ____________________ Outcome (with case definition): ____________________ Time/follow-up period: ____________________ FINER check: [ ] Feasible given current resources and timeframe [ ] Interesting to the intended audience [ ] Novel relative to existing cohort evidence [ ] Ethical, including consent and follow-up burden [ ] Relevant to clinical or policy decisions Sub-questions (max 4-5, same core population/exposure): ____________________
Pubrica AcademyWritten and maintained by Pubrica’s subject matter experts. Articles are revised when the underlying standards change, and each article states the date on which it was last reviewed.
How Pubrica can help
Pubrica’s study design advisory service tests a prospective study’s question against PICOT and FINER before the protocol is finalized, so that the exposure and outcome definitions are fixed and ready for registration.